Skip to main content

Table 6 Type of antipsychotic combinations in patients with LAI antipsychotics

From: Antipsychotic polypharmacy in a regional health service: a population-based study

 

Monotherapy (N = 47,386)

Combination with one oral antipsychotics (N = 5,692)

Combination with ≥2 antipsychotics(N = 4,163)

  

FGA

SGA

 

Risperidone LAI

654 (1.4%)

95 (1.6%)

445 (7.8%)

948 (22.7%)

Fluphenazine

212 (0.4%)

49 (0.8%)

74 (1.3%)

405 (9.7%)

Zuclopenthixol LAI

202 (0.4%)

46 (0.8%)

178 (3.1%)

424 (10.1%)

Pipothiazine

70 (0.1%)

27 (0.4%)

49 (0.8%)

111 (2.6%)

TOTAL LAI

1,138 (2.4%)

217 (3.8%)

746 (13.1%)

1,699 (40.8%)

  1. LAI long-acting injection.
  2. FGA first generation antipsychotic.
  3. SGA second generation antipsychotic.